Multigenerational and transgenerational effects of endocrine disrupting chemicals: A role for altered epigenetic regulation?

Seminars in Cell and Developmental Biology

Volumn 43, Issue , 2015, Pages 66-75

  Xin, Frances ^a   Susiarjo, Martha ^a   Bartolomei, Marisa S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bisphenol A; Endocrine disrupting chemicals; Epigenetics; Parabens; Phthalates; Transgenerational inheritance

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; 4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; PHTHALIC ACID; UNTRANSLATED RNA; BENZHYDRYL DERIVATIVE; PHENOL DERIVATIVE; PHTHALIC ACID DERIVATIVE;

ALLELE; DNA METHYLATION; EPIGENETICS; GENETIC REGULATION; HUMAN; IN VITRO STUDY; INCIDENCE; MULTIGENERATIONAL EPIGENETIC INHERITANCE; NONHUMAN; PHENOTYPE; PRIMORDIAL GERM CELL; PROMOTER REGION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; TRANSGENERATIONAL EPIGENETIC INHERITANCE; X CHROMOSOME INACTIVATION; ANIMAL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; INHERITANCE; MOUSE;

ANIMALS; BENZHYDRYL COMPOUNDS; DNA METHYLATION; ENDOCRINE DISRUPTORS; EPIGENESIS, GENETIC; HUMANS; INHERITANCE PATTERNS; MICE; PARABENS; PHENOLS; PHENOTYPE; PHTHALIC ACIDS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, UNTRANSLATED;

EID: 84948114602     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.05.008     Document Type: Review

References (121)

1. Dover G.J. The Barker hypothesis: how pediatricans will diagnose and prevent common adult-onset diseases. Trans. Am. Clin. Climatol. Assoc. 2009, 120:199-207.
2. Barker D.J., Winter P.D., Osmond C., Margetts B., Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2:577-580.
3. Bergman Å., Heindel J.J., Jobling S., Kidd K.A., Zoeller R.T., Jobling S.K.K.A. State of the Science of Endocrine Disrupting Chemicals 2012: An Assessment of the State of the Science of Endocrine Disruptors Prepared by a Group of Experts for the United Nations Environment Programme and World Health Organization 2013, World Health Organization.
4. Yoon K., Kwack S.J., Kim H.S., Lee B.-M. Estrogenic endocrine-disrupting chemicals: molecular mechanisms of actions on putative human diseases. J. Toxicol. Environ. Health B: Crit. Rev. 2014, 17:127-174.
5. de Wildt S.N., Kearns G.L., Leeder J.S., van den Anker J.N. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin. Pharmacokinet. 1999, 36:439-452.
6. Choudhary D., Jansson I., Schenkman J.B., Sarfarazi M., Stoilov I. Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch. Biochem. Biophys. 2003, 414:91-100.
7. Saitou M., Kagiwada S., Kurimoto K. Epigenetic reprogramming in mouse pre-implantation development and primordial germ cells. Development 2012, 139:15-31.
8. Heard E., Martienssen R.A. Transgenerational epigenetic inheritance: myths and mechanisms. Cell 2014, 157:95-109.
9. Spaethling J.M., Eberwine J.H. Single-cell transcriptomics for drug target discovery. Curr. Opin. Pharmacol. 2013, 13:786-790.
10. Brind'Amour J., Liu S., Hudson M., Chen C., Karimi M.M., Lorincz M.C. An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations. Nat. Commun. 2015, 6:6033.
11. Jensen Peña C., Monk C., Champagne F.A. Epigenetic effects of prenatal stress on 11β-hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. PLOS ONE 2012, 7:e39791.
12. Aubert N., Ameller T., Legrand J.-J. Systemic exposure to parabens: pharmacokinetics, tissue distribution, excretion balance and plasma metabolites of [14C]-methyl-, propyl- and butylparaben in rats after oral, topical or subcutaneous administration. Food Chem. Toxicol. 2012, 50:445-454.
13. Schübeler D. Function and information content of DNA methylation. Nature 2015, 517:321-326.
14. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
15. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21:381-395.
16. Falkenberg K.J., Johnstone R.W. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 2014, 13:673-691.
17. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
18. Robertson K.D. DNA methylation and chromatin - unraveling the tangled web. Oncogene 2002, 21:5361-5379.
19. Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010, 28:1057-1068.
20. Greathouse K.L., Bredfeldt T., Everitt J.I., Lin K., Berry T., Kannan K., et al. Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Mol. Cancer Res. 2012, 10:546-557.
21. Swedenborg E., Rüegg J., Mäkelä S., Pongratz I. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J. Mol. Endocrinol. 2009, 43:1-10.
22. Björnström L., Sjöberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19:833-842.
23. Wong R.L.Y., Walker C.L. Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome. Clin. Cancer Res. 2013, 19:3732-3737.
24. Peretz J., Vrooman L., Ricke W.A., Hunt P.A., Ehrlich S., Hauser R., et al. Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ. Health Perspect. 2014, 122:775-786.
25. Kurita H., Schnekenburger M., Ovesen J.L., Xia Y., Puga A. The Ah receptor recruits IKKα to its target binding motifs to phosphorylate serine-10 in histone H3 required for transcriptional activation. Toxicol. Sci. 2014, 139:121-132.
26. Yang X., Phillips D.L., Ferguson A.T., Nelson W.G., Herman J.G., Davidson N.E. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res. 2001, 61:7025-7029.
27. Ottaviano Y.L., Issa J.P., Parl F.F., Smith H.S., Baylin S.B., Davidson N.E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 1994, 54:2552-2555.
28. Mo R., Rao S.M., Zhu Y.-J. Identification of the MLL2 complex as a coactivator for estrogen receptor alpha. J. Biol. Chem. 2006, 281:15714-15720.
29. Kerdivel G., Habauzit D., Pakdel F. Assessment and molecular actions of endocrine-disrupting chemicals that interfere with estrogen receptor pathways. Int. J. Endocrinol. 2013, 2013:501851-501914.
30. Minamiyama Y., Ichikawa H., Takemura S., Kusunoki H., Naito Y., Yoshikawa T. Generation of reactive oxygen species in sperms of rats as an earlier marker for evaluating the toxicity of endocrine-disrupting chemicals. Free Radic. Res. 2010, 44:1398-1406.
31. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ. Health Perspect. 2005, 113:391-395.
32. Saal vom F.S., Welshons W.V. Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure. Mol. Cell. Endocrinol. 2014, 398:101-113.
33. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.-H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33:378-455.
34. Nanjappa M.K., Simon L., Akingbemi B.T. The industrial chemical bisphenol A (BPA) interferes with proliferative activity and development of steroidogenic capacity in rat Leydig cells. Biol. Reprod. 2012, 86:135-141.
35. Trasande L., Attina T.M., Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 2012, 308:1113-1121.
36. Ashley-Martin J., Dodds L., Arbuckle T.E., Ettinger A.S., Shapiro G.D., Fisher M., et al. A birth cohort study to investigate the association between prenatal phthalate and bisphenol A exposures and fetal markers of metabolic dysfunction. Environ. Health 2014, 13:84.
37. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 2001, 109:675-680.
38. Rosenfeld C.S. Bisphenol A and phthalate endocrine disruption of parental and social behaviors. Front. Neurosci. 2015, 9:57.
39. Ryan B.C., Vandenbergh J.G. Developmental exposure to environmental estrogens alters anxiety and spatial memory in female mice. Horm. Behav. 2006, 50:85-93.
40. Xu X.-H., Zhang J., Wang Y.-M., Ye Y.-P., Luo Q.-Q. Perinatal exposure to bisphenol-A impairs learning-memory by concomitant down-regulation of N-methyl-d-aspartate receptors of hippocampus in male offspring mice. Horm. Behav. 2010, 58:326-333.
41. Ishido M., Masuo Y., Kunimoto M., Oka S., Morita M., Bisphenol A. causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J. Neurosci. Res. 2004, 76:423-433.
42. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13056-13061.
43. Rosenfeld C.S., Sieli P.T., Warzak D.A., Ellersieck M.R., Pennington K.A., Roberts R.M. Maternal exposure to bisphenol A and genistein has minimal effect on A(vy)/a offspring coat color but favors birth of agouti over nonagouti mice. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:537-542.
44. Anderson O.S., Nahar M.S., Faulk C., Jones T.R., Liao C., Kannan K., et al. Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ Mol Mutagen 2012, 53:334-342.
45. Prins G.S., Tang W.-Y., Belmonte J., Ho S.-M. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic Clin. Pharmacol. Toxicol. 2008, 102:134-138.
46. Susiarjo M., Sasson I., Mesaros C., Bartolomei M.S. Bisphenol a exposure disrupts genomic imprinting in the mouse. PLoS Genet. 2013, 9:e1003401.
47. Bromer J.G., Zhou Y., Taylor M.B., Doherty L., Taylor H.S. Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J. 2010, 24:2273-2280.
48. Chao H.-H., Zhang X.-F., Chen B., Pan B., Zhang L.-J., Li L., et al. Bisphenol A exposure modifies methylation of imprinted genes in mouse oocytes via the estrogen receptor signaling pathway. Histochem. Cell Biol. 2012, 137:249-259.
49. Zhang H.-Q., Zhang X.-F., Zhang L.-J., Chao H.-H., Pan B., Feng Y.-M., et al. Fetal exposure to bisphenol A affects the primordial follicle formation by inhibiting the meiotic progression of oocytes. Mol. Biol. Rep. 2012, 39:5651-5657.
50. Doshi T., Mehta S.S., Dighe V., Balasinor N., Vanage G. Hypermethylation of estrogen receptor promoter region in adult testis of rats exposed neonatally to bisphenol A. Toxicology 2011, 289:74-82.
51. Wolstenholme J.T., Taylor J.A., Shetty S.R.J., Edwards M., Connelly J.J., Rissman E.F. Gestational exposure to low dose bisphenol A alters social behavior in juvenile mice. PLoS ONE 2011, 6:e25448.
52. Ho S.-M., Tang W.-Y., Belmonte de Frausto J., Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006, 66:5624-5632.
53. Ma Y., Xia W., Wang D.Q., Wan Y.J., Xu B., Chen X., et al. Hepatic DNA methylation modifications in early development of rats resulting from perinatal BPA exposure contribute to insulin resistance in adulthood. Diabetologia 2013, 56:2059-2067.
54. Nahar M.S., Liao C., Kannan K., Harris C., Dolinoy D.C. In utero bisphenol A concentration, metabolism, and global DNA methylation across matched placenta, kidney, and liver in the human fetus. Chemosphere 2015, 124:54-60.
55. Daxinger L., Whitelaw E. Understanding transgenerational epigenetic inheritance via the gametes in mammals. Nat. Rev. Genet. 2012, 13:153-162.
56. Xu X., Yang Y., Wang R., Wang Y., Ruan Q., Lu Y. Perinatal exposure to di-(2-ethylhexyl) phthalate affects anxiety- and depression-like behaviors in mice. Chemosphere 2015, 124:22-31.
57. Doherty L.F., Bromer J.G., Zhou Y., Aldad T.S., Taylor H.S. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm. Cancer 2010, 1:146-155.
58. Dhimolea E., Wadia P.R., Murray T.J., Settles M.L., Treitman J.D., Sonnenschein C., et al. Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development. PLOS ONE 2014, 9:e99800.
59. Wong R.L.Y., Wang Q., Treviño L.S., Bosland M.C., Chen J., Medvedovic M., et al. Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostate. Epigenetics 2015, 10:127-134.
60. Cho H., Kim S.J., Park H.-W., Oh M.-J., Yu S.Y., Lee S.Y., et al. A relationship between miRNA and gene expression in the mouse Sertoli cell line after exposure to bisphenol A. BioChip. J. 2010, 4:75-81.
61. Avissar-Whiting M., Veiga K.R., Uhl K.M., Maccani M.A., Gagne L.A., Moen E.L., et al. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod. Toxicol. 2010, 29:401-406.
62. Susiarjo M., Xin F., Bansal A., Stefaniak M., Li C., Simmons R.A., et al. Bisphenol A exposure disrupts metabolic health across multiple generations in the mouse. Endocrinology 2015, en20142027.
63. Wolstenholme J.T., Goldsby J.A., Rissman E.F. Transgenerational effects of prenatal bisphenol A on social recognition. Horm. Behav. 2013, 64:833-839.
64. Manikkam M., Tracey R., Guerrero-Bosagna C., Skinner M.K. Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. PLOS ONE 2013, 8:e55387.
65. Koch H.M., Preuss R., Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int. J. Androl. 2006, 29:155-165. discussion 181-185.
66. Bosnir J., Puntarić D., Skes I., Klarić M., Simić S., Zorić I. Migration of phthalates from plastic products to model solutions. Coll. Antropol. 2003, 27(Suppl. 1):23.
67. Fisher J.S. Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. Reproduction 2004, 127:305-315.
68. Skakkebaek N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 2001, 16:972-978.
69. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., Calafat A.M., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 2005, 113:1056-1061.
70. Mendiola J., Stahlhut R.W., Jørgensen N., Liu F., Swan S.H. Shorter anogenital distance predicts poorer semen quality in young men in Rochester, New York. Environ. Health Perspect. 2011, 119:958-963.
71. Stahlhut R.W., van Wijngaarden E., Dye T.D., Cook S., Swan S.H. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ. Health Perspect. 2007, 115:876-882.
72. Rajesh P., Balasubramanian K. Phthalate exposure in utero causes epigenetic changes and impairs insulin signalling. J. Endocrinol. 2014, 223:47-66.
73. Hao C., Cheng X., Xia H., Ma X. The endocrine disruptor mono-(2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice. Biosci. Rep. 2012, 32:619-629.
74. Betz A., Jayatilaka S., Joshi J., Ramanan S., Debartolo D., Pylypiw H., et al. Chronic exposure to benzyl butyl phthalate (BBP) alters social interaction and fear conditioning in male adult rats: alterations in amygdalar MeCP2, ERK1/2 and ERα. Neuroendocrinol. Lett. 2013, 34:347-358.
75. Wang D.-C., Chen T.-J., Lin M.-L., Jhong Y.-C., Chen S.-C. Exercise prevents the increased anxiety-like behavior in lactational di-(2-ethylhexyl) phthalate-exposed female rats in late adolescence by improving the regulation of hypothalamus-pituitary-adrenal axis. Horm. Behav. 2014, 66:674-684.
76. LaRocca J., Binder A.M., McElrath T.F., Michels K.B. The impact of first trimester phthalate and phenol exposure on IGF2/H19 genomic imprinting and birth outcomes. Environ. Res. 2014, 133:396-406.
77. Zhao Y., Shi H.-J., Xie C.-M., Chen J., Laue H. Environ. Mol. Mutagen. 2014, 56.
78. Martinez-Arguelles D.B., Papadopoulos V. Identification of hot spots of DNA methylation in the adult male adrenal in response to in utero exposure to the ubiquitous endocrine disruptor plasticizer di-(2-ethylhexyl) phthalate. Endocrinology 2015, 156:124-133.
79. Kostka G., Urbanek-Olejnik K., Wiadrowska B. Di-butyl phthalate-induced hypomethylation of the c-myc gene in rat liver. Toxicol. Ind. Health 2010, 26:407-416.
80. Wu S., Zhu J., Li Y., Lin T., Gan L., Yuan X., et al. Dynamic effect of di-2-(ethylhexyl) phthalate on testicular toxicity: epigenetic changes and their impact on gene expression. Int. J. Toxicol. 2010, 29:193-200.
81. Kang S.C., Lee B.-M. DNA methylation of estrogen receptor alpha gene by phthalates. J. Toxicol. Environ. Health Part A 2005, 68:1995-2000.
82. Hsieh T.-H., Tsai C.-F., Hsu C.-Y., Kuo P.-L., Lee J.-N., Chai C.-Y., et al. Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway. FASEB J. 2012, 26:778-787.
83. Hsieh T.-H., Tsai C.-F., Hsu C.-Y., Kuo P.-L., Lee J.-N., Chai C.-Y., et al. Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells. Toxicol. Sci. 2012, 128:365-376.
84. Guida N., Laudati G., Galgani M., Santopaolo M., Montuori P., Triassi M., et al. Histone deacetylase 4 promotes ubiquitin-dependent proteasomal degradation of Sp3 in SH-SY5Y cells treated with di(2-ethylhexyl)phthalate (DEHP), determining neuronal death. Toxicol. Appl. Pharmacol. 2014, 280:190-198.
85. Kuo C.-H., Hsieh C.-C., Kuo H.-F., Huang M.-Y., Yang S.-N., Chen L.-C., et al. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation. Allergy 2013, 68:870-879.
86. Doyle T.J., Bowman J.L., Windell V.L., McLean D.J., Kim K.H. Transgenerational effects of di-(2-ethylhexyl) phthalate on testicular germ cell associations and spermatogonial stem cells in mice. Biol. Reprod. 2013, 88:112-122.
87. Li L., Zhang T., Qin X.-S., Ge W., Ma H.-G., Sun L.-L., et al. Exposure to diethylhexyl phthalate (DEHP) results in a heritable modification of imprint genes DNA methylation in mouse oocytes. Mol. Biol. Rep. 2014, 41:1227-1235.
88. Błedzka D., Gromadzińska J., Wasowicz W. Parabens. From environmental studies to human health. Environ. Int. 2014, 67:27-42.
89. Koeppe E.S., Ferguson K.K., Colacino J.A., Meeker J.D. Relationship between urinary triclosan and paraben concentrations and serum thyroid measures in NHANES 2007-2008. Sci. Total Environ. 2013, 445-446:299-305.
90. Nandi-Munshi D., Taplin C.E. Thyroid-related neurological disorders and complications in children. Pediatr. Neurol. 2015, 52:373-382.
91. Zhang L., Dong L., Ding S., Qiao P., Wang C., Zhang M., et al. Effects of n-butylparaben on steroidogenesis and spermatogenesis through changed E: levels in male rat offspring. Environ. Toxicol. Pharmacol. 2014, 37:705-717.
92. McMillen I.C., Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol. Rev. 2005, 85:571-633.
93. Park C.J., Nah W.H., Lee J.E., Oh Y.S., Gye M.C. Butyl paraben-induced changes in DNA methylation in rat epididymal spermatozoa. Andrologia 2012, 44(Suppl. 1):187-193.
94. Pugazhendhi D., Sadler A.J., Darbre P.D. Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells. J. Appl. Toxicol. 2007, 27:67-77.
95. Herbst A.L., Ulfelder H., Poskanzer D.C., Longo L.D. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 1971, 181:1999.
96. Hilakivi-Clarke L. Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters. Breast Cancer Res. 2014, 16:208.
97. Bromer J.G., Wu J., Zhou Y., Taylor H.S. Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology 2009, 150:3376-3382.
98. Couse J.F., Dixon D., Yates M., Moore A.B., Ma L., Maas R., et al. Estrogen receptor-alpha knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. Dev. Biol. 2001, 238:224-238.
99. Li Y., Hamilton K.J., Lai A.Y., Burns K.A., Li L., Wade P.A., et al. Diethylstilbestrol (DES)-stimulated hormonal toxicity is mediated by ERα alteration of target gene methylation patterns and epigenetic modifiers (DNMT3A, MBD2, and HDAC2) in the mouse seminal vesicle. Environ. Health Perspect. 2014, 122:262-268.
100. Anway M.D., Cupp A.S., Uzumcu M., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005, 308:1466-1469.
101. Stouder C., Paoloni-Giacobino A. Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm. Reproduction 2010, 139:373-379.
102. Iqbal K., Tran D.A., Li A.X., Warden C., Bai A.Y., Singh P., et al. Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming. Genome Biol. 2015, 16:59.
103. Brieño-Enríquez M.A., García-López J., Cárdenas D.B., Guibert S., Cleroux E., Děd L., et al. Exposure to endocrine disruptor induces transgenerational epigenetic deregulation of microRNAs in primordial germ cells. PLOS ONE 2015, 10:e0124296.
104. Manikkam M., Haque M.M., Guerrero-Bosagna C., Nilsson E.E., Skinner M.K. Pesticide methoxychlor promotes the epigenetic transgenerational inheritance of adult-onset disease through the female germline. PLOS ONE 2014, 9:e102091.
105. Clifton V.L. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta 2010, 31(Suppl.):S33-S39.
106. Rubin B.S., Lenkowski J.R., Schaeberle C.M., Vandenberg L.N., Ronsheim P.M., Soto A.M. Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology 2006, 147:3681-3691.
107. Arnold A.P. Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J. Neuroendocrinol. 2009, 21:377-386.
108. Alonso A., Gonzalez C. Neuroprotective role of estrogens: relationship with insulin/IGF-1 signaling. Front. Biosci. (Elite Ed.) 2012, 4:607-619.
109. Berletch J.B., Yang F., Disteche C.M. Escape from X inactivation in mice and humans. Genome Biol. 2010, 11:213.
110. Hotchkiss A.K., Rider C.V., Furr J., Howdeshell K.L., Blystone C.R., Wilson V.S., et al. In utero exposure to an AR antagonist plus an inhibitor of fetal testosterone synthesis induces cumulative effects on F1 male rats. Reprod. Toxicol. 2010, 30:261-270.
111. Friis R. Essentials of Environmental Health 2011, Jones & Bartlett Publishers.
112. Bredfeldt T.G., Greathouse K.L., Safe S.H., Hung M.-C., Bedford M.T., Walker C.L. Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT. Mol. Endocrinol. 2010, 24:993-1000.
113. Cowin P.A., Gold E., Aleksova J., O'Bryan M.K., Foster P.M.D., Scott H.S., et al. Vinclozolin exposure in utero induces postpubertal prostatitis and reduces sperm production via a reversible hormone-regulated mechanism. Endocrinology 2010, 151:783-792.
114. Skinner M.K., Guerrero-Bosagna C., Haque M., Nilsson E., Bhandari R., McCarrey J.R. Environmentally induced transgenerational epigenetic reprogramming of primordial germ cells and the subsequent germ line. PLOS ONE 2013, 8:e66318.
115. Stouder C., Paoloni-Giacobino A. Specific transgenerational imprinting effects of the endocrine disruptor methoxychlor on male gametes. Reproduction 2011, 141:207-216.
116. Zama A.M., Uzumcu M. Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes. Endocrinology 2009, 150:4681-4691.
117. Chaturvedi N.K., Kumar S., Negi S., Tyagi R.K. Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders. Mol. Cell. Biochem. 2010, 345:291-308.
118. Somm E., Stouder C., Paoloni-Giacobino A. Effect of developmental dioxin exposure on methylation and expression of specific imprinted genes in mice. Reprod. Toxicol. 2013, 35:150-155.
119. Ohsako S., Miyabara Y., Nishimura N., Kurosawa S., Sakaue M., Ishimura R., et al. Maternal exposure to a low dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppressed the development of reproductive organs of male rats: dose-dependent increase of mRNA levels of 5alpha-reductase type 2 in contrast to decrease of androgen receptor in the pubertal ventral prostate. Toxicol. Sci. 2001, 60:132-143.
120. Manikkam M., Tracey R., Guerrero-Bosagna C., Skinner M.K. Dioxin (TCDD) induces epigenetic transgenerational inheritance of adult onset disease and sperm epimutations. PLOS ONE 2012, 7:e46249.
121. Chamorro-García R., Sahu M., Abbey R.J., Laude J., Pham N., Blumberg B. Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environ. Health Perspect. 2013, 121:359-366.